Cite
Dynamic whole-body [18F]FES PET/CT increases lesion visibility in patients with metastatic breast cancer
MLA
Mette A. Pedersen, et al. “Dynamic Whole-Body [18F]FES PET/CT Increases Lesion Visibility in Patients with Metastatic Breast Cancer.” EJNMMI Research, vol. 14, no. 1, Mar. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s13550-024-01080-y.
APA
Mette A. Pedersen, Ole L. Munk, André H. Dias, Johanne H. Steffensen, Anders L. Møller, Anna Lyhne Johnsson, Kim Vang Hansen, Dirk Bender, Steen Jakobsen, Morten Busk, Lars C. Gormsen, Trine Tramm, Signe Borgquist, & Mikkel H. Vendelbo. (2024). Dynamic whole-body [18F]FES PET/CT increases lesion visibility in patients with metastatic breast cancer. EJNMMI Research, 14(1), 1–12. https://doi.org/10.1186/s13550-024-01080-y
Chicago
Mette A. Pedersen, Ole L. Munk, André H. Dias, Johanne H. Steffensen, Anders L. Møller, Anna Lyhne Johnsson, Kim Vang Hansen, et al. 2024. “Dynamic Whole-Body [18F]FES PET/CT Increases Lesion Visibility in Patients with Metastatic Breast Cancer.” EJNMMI Research 14 (1): 1–12. doi:10.1186/s13550-024-01080-y.